PharmaCyte Biotech Stock (NASDAQ: PMCB) stock price, news, charts, stock research, profile.
Open | $2.00 |
Close | $2.02 |
Volume / Avg. | 25.60K / 17.57K |
Day Range | 1.95 - 2.06 |
52 Wk Range | 1.76 - 2.84 |
Market Cap | $16.65M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 48 |
Short Interest | 0.19% |
Days to Cover | 1.66 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of PharmaCyte Biotech (NASDAQ:PMCB) through any online brokerage.
Other companies in PharmaCyte Biotech’s space includes: Vincerx Pharma (NASDAQ:VINC), Galecto (NASDAQ:GLTO), Immuron (NASDAQ:IMRN), Imunon (NASDAQ:IMNN) and Evaxion Biotech (NASDAQ:EVAX).
There is no analysis for PharmaCyte Biotech.
There is no analysis for PharmaCyte Biotech to provide a consensus price target.
The stock price for PharmaCyte Biotech (NASDAQ: PMCB) is $1.97 last updated July 24, 2024 at 7:50 AM EDT.
There are no upcoming dividends for PharmaCyte Biotech.
PharmaCyte Biotech’s Q1 earnings are confirmed for Monday, September 16, 2024.
There is no upcoming split for PharmaCyte Biotech.
PharmaCyte Biotech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.